Evidence map›Paper›PMID 22521466›Full record

ArticleNeurobiology of disease2012

Creatine pretreatment protects cortical axons from energy depletion in vitro.

Hua Shen, Mark P Goldberg

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Cardiovascular risks impact human brainProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Hua ShenHope Center for Neurological Disorders and Department of Neurology, Washington University School of Medicine, Saint Louis, MO 63110, USA. shenhu@wudosis.wustl.edu
Mark P Goldberg
Hope Center for Neurological Disorders · USWashington University in St. Louis · US

Funding

ZINC AND ISCHEMIC BRAIN INJURYP01NS032636 · NINDS · WASHINGTON UNIVERSITY · PI LEE, JIN-MOO · 1995 to 2010
$13.2M
Washington University Center for Translational NeuroscienceP30NS057105 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2006 to 2011
$8.7M
OLIGODENDROCYTE DEATH IN CEREBRAL ISCHEMIAR01NS036265 · NINDS · WASHINGTON UNIVERSITY · PI GOLDBERG, MARK PAUL · 1997 to 2007
$1.7M
NINDS NIH HHS P01 NS032636NINDS NIH HHS P30 NS057105NINDS NIH HHS R01 NS036265
6 · The paper itself

Abstract

Creatine is a natural nitrogenous guanidino compound involved in bioenergy metabolism. Although creatine has been shown to protect neurons of the central nervous system (CNS) from experimental hypoxia/ischemia, it remains unclear if creatine may also protect CNS axons, and if the potential axonal protection depends on glial cells. To evaluate the direct impact of creatine on CNS axons, cortical axons were cultured in a separate compartment from their somas and proximal neurites using a modified two-compartment culture device. Axons in the axon compartment were subjected to acute energy depletion, an in vitro model of white matter ischemia, by exposure to 6mM sodium azide for 30 min in the absence of glucose and pyruvate. Energy depletion reduced axonal ATP by 65%, depolarized axonal resting potential, and damaged 75% of axons. Application of creatine (10 mM) to both compartments of the culture at 24h prior to energy depletion significantly reduced axonal damage by 50%. In line with the role of creatine in the bioenergy metabolism, this application also alleviated the axonal ATP loss and depolarization. Inhibition of axonal depolarization by blocking sodium influx with tetrodotoxin also effectively reduced the axonal damage caused by energy depletion. Further study revealed that the creatine effect was independent of glial cells, as axonal protection was sustained even when creatine was applied only to the axon compartment (free from somas and glial cells) for as little as 2h. In contrast, application of creatine after energy depletion did not protect axons. The data provide the first evidence that creatine pretreatment may directly protect CNS axons from energy deficiency.

Indexed as

AnimalsAxonsCells, CulturedCerebral CortexCreatineEnergy MetabolismMembrane PotentialsMiceMice, Inbred C57BLNeuroprotective AgentsTreatment OutcomeCreatineNeuroprotective Agents

Identifiers

PMID22521466
PMCPMC3367034
OpenAlexW2068665975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.